SPE2D226D0007.pdf

This is a Solicitation/Contract Order for Commercial Items (Standard Form 1449) issued by the Defense Logistics Agency (DLA) for pharmaceutical products. The contract was awarded to AvKARE LLC on February 17, 2026, under Solicitation SPE2D2-26-R-0001. The contract number is SPE2D25-D-0014, with a total estimated value of $1,834,297.80 over a five-year period (base year plus four option years).

The contract covers two pharmaceutical products manufactured by Anneal Pharmaceuticals (located in Brookhaven, NY 11719) and distributed by AvKARE LLC: (1) Metaxalone 800 MG Tablets in 100-count bottles (NDC 42291-0985-01) at $20.48 per bottle, with estimated annual quantities of 6,297 bottles; and (2) Metaxalone 800 MG Tablets in 500-count bottles (NDC 42291-0985-50) at $99.00 per bottle, with estimated annual quantities of 2,403 bottles. Pricing remains constant across all five contract years. The solicitation was issued on November 7, 2025, with an offer deadline of January 5, 2026. DLA Pharmaceutical Prime Vendors will administer the contract, with delivery to DLA and VA Pharmaceutical Prime Vendors as specified in Appendix A. The contract includes comprehensive FAR and DFARS clauses addressing compliance with federal regulations, small business subcontracting, labor standards, supply chain security, and various statutory requirements applicable to commercial acquisitions.